Edition:
India

ADMA Biologics Inc (ADMA.OQ)

ADMA.OQ on NASDAQ Stock Exchange Capital Market

2.63USD
15 Dec 2017
Change (% chg)

$0.15 (+6.05%)
Prev Close
$2.48
Open
$2.47
Day's High
$2.73
Day's Low
$2.47
Volume
159,170
Avg. Vol
30,022
52-wk High
$5.74
52-wk Low
$2.02

Latest Key Developments (Source: Significant Developments)

Adma Biologics prices follow-on offering of 17.0 mln shares
Thursday, 9 Nov 2017 

Nov 9 (Reuters) - Adma Biologics Inc :Adma Biologics announces pricing of follow-on offering.Adma Biologics Inc - ‍pricing of offering of approximately 17.0 million shares of its common stock at price of $2.15 per share​.  Full Article

ADMA Biologics now sees offering‍​ of 13.6 mln shares of common stock - SEC filing
Thursday, 9 Nov 2017 

Nov 8 (Reuters) - ADMA Biologics Inc ::Now sees offering‍​ of 13.6 million shares of its common stock, up from previous filing of 10.2 million shares - SEC filing.  Full Article

ADMA Biologics Q3 loss per share $0.59
Saturday, 4 Nov 2017 

Nov 3 (Reuters) - ADMA Biologics Inc ::ADMA Biologics provides corporate update and reports third quarter 2017 financial results.Q3 loss per share $0.59.Q3 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S.Q3 revenue rose 61 percent to $4.7 million.Q3 revenue view $6.5 million -- Thomson Reuters I/B/E/S.  Full Article

ADMA Biologics says ‍loss per share was $0.59 for fiscal quarter ended Sept 30​
Saturday, 4 Nov 2017 

Nov 3 (Reuters) - Adma Biologics Inc :ADMA Biologics Inc says ‍for fiscal quarter ended September 30, loss per share was $0.59 - SEC filing​.ADMA Biologics Inc - qtrly total revenues $4.7 million versus $2.9 million ‍​.  Full Article

Adma Biologics Inc files for offering of up to $28.75‍​ million of common stock
Thursday, 12 Oct 2017 

Oct 11 (Reuters) - Adma Biologics Inc ::Adma Biologics Inc files for offering of up to $28.75‍​ million of common stock .  Full Article

ADMA Biologics ‍enters into credit agreement for up to $40 mln with affiliated entities of Marathon Asset Management​
Wednesday, 11 Oct 2017 

Oct 11 (Reuters) - ADMA Biologics Inc ::ADMA Biologics Inc - ‍entered into a credit agreement for up to $40 million with affiliated entities of marathon asset management​.ADMA Biologics - ‍will use proceeds from transaction to refinance principal and accrued interest of outstanding secured loan with oxford finance.  Full Article

ADMA Biologics reports second quarter 2016 results
Saturday, 13 Aug 2016 

ADMA Biologics Inc : ADMA Biologics reports second quarter 2016 results . Q2 earnings per share view $-0.39 -- Thomson Reuters I/B/E/S . Q2 loss per share $0.50 . Q2 revenue view $2.2 million -- Thomson Reuters I/B/E/S . Qtrly total revenue $2.3 million versus $1.3 million .ADMA Biologics reports second quarter 2016 results.  Full Article

Adma Biologics receives CRL from FDA for pending biologics license application
Saturday, 30 Jul 2016 

Adma Biologics Inc : CRL did not cite any concerns with clinical safety and efficacy data for ri-002 submitted by adma in bla . FDA has not requested any additional clinical studies be conducted prior to fda approval of ri-002 for pidd. . Adma biologics receives complete response letter from fda for pending biologics license application . FDA identified in crl certain outstanding inspection issues and deficiencies at adma's third-party contract manufacturers .FDA in CRL requested documentation of corrections for a number of issues related to adma's third-party contract manufacturers.  Full Article

Adma Biologics Q1 loss per share $0.43
Saturday, 14 May 2016 

Adma Biologics Inc : Adma Biologics reports first quarter 2016 results . Q1 revenue $2.1 million versus I/B/E/S view $2.2 million . Q1 loss per share $0.43 .Q1 earnings per share view $-0.37 -- Thomson Reuters I/B/E/S.  Full Article

Adma Biologics further enhances cash position by securing $4 mln in additional capital
Saturday, 14 May 2016 

Adma Biologics Inc : Amendment provides option to draw an additional $5 million upon approval for its Biologics license application for ri-002 from FDA .Adma Biologics further enhances cash position by securing $4.0 million in additional capital through amended loan and security agreement with oxford finance.  Full Article